Servier, a French pharmaceutical group, has completed its acquisition of the muscular dystrophy business of Edgewise Therapeutics (Nasdaq: EWTX) for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions